bibliographicCitation |
Fagerberg B, Schuster H, Birketvedt GS, Tonstad S, Ohman KP, Gause-Nilsson I; SIR Study Group. Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPARalpha/gamma agonist, tesaglitazar. Diab Vasc Dis Res. 2007 Sep;4(3):174–80. doi: 10.3132/dvdr.2007.038. PMID: 17907107. |